Sone Capital Management LLC Takes $6.97 Million Position in Stryker Corporation $SYK

Sone Capital Management LLC acquired a new position in Stryker Corporation (NYSE:SYK) in the second quarter, Holdings Channel.com reports. The institutional investor acquired 22,151 shares of the medical technology company’s stock, valued at approximately $6,974,000.

A number of other hedge funds and other institutional investors have also bought and sold shares of the company. Gables Capital Management Inc. acquired a new position in Stryker during the 2nd quarter worth $25,000. Kilter Group LLC acquired a new stake in shares of Stryker in the second quarter valued at about $25,000. Godfrey Financial Associates Inc. acquired a new stake in shares of Stryker in the fourth quarter valued at about $26,000. Sankala Group LLC bought a new position in shares of Stryker in the fourth quarter worth about $26,000. Finally, Compass Financial Management LLC acquired a new position in shares of Stryker during the 2nd quarter worth about $27,000. 77.09% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of analysts have issued reports on the company. Canaccord Genuity Group lowered their target price on Stryker from $435.00 to $400.00 and set a “buy” rating on the stock in a report on Friday, May 1st. JPMorgan Chase & Co. cut their price target on Stryker from $400.00 to $350.00 and set an “overweight” rating for the company in a report on Friday, July 31st. Needham & Company LLC reduced their price objective on Stryker from $454.00 to $418.00 and set a “buy” rating for the company in a research report on Friday, May 1st. Deutsche Bank Aktiengesellschaft set a $315.00 price objective on shares of Stryker in a research note on Friday, May 1st. Finally, Wall Street Zen raised shares of Stryker from a “hold” rating to a “buy” rating in a research report on Saturday, August 8th. One equities research analyst has rated the stock with a Strong Buy rating, seventeen have given a Buy rating and six have issued a Hold rating to the stock. According to MarketBeat, Stryker has a consensus rating of “Moderate Buy” and an average price target of $386.28.

Insider Activity at Stryker

In other Stryker news, Director Ronda E. Stryker sold 50,000 shares of Stryker stock in a transaction that occurred on Wednesday, August 19th. The stock was sold at an average price of $340.10, for a total transaction of $17,005,000.00. Following the sale, the director directly owned 2,251,375 shares of the company’s stock, valued at approximately $765,692,637.50. The trade was a 2.17% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, VP Robert S. Fletcher sold 4,544 shares of the stock in a transaction that occurred on Thursday, May 28th. The stock was sold at an average price of $306.87, for a total value of $1,394,417.28. Following the completion of the transaction, the vice president directly owned 10,582 shares of the company’s stock, valued at approximately $3,247,298.34. The trade was a 30.04% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 355,370 shares of company stock valued at $119,447,201 over the last quarter. 4.60% of the stock is owned by company insiders.

Stryker Stock Down 0.5%

SYK stock opened at $327.80 on Tuesday. Stryker Corporation has a twelve month low of $281.00 and a twelve month high of $396.86. The company has a quick ratio of 1.33, a current ratio of 2.16 and a debt-to-equity ratio of 0.59. The company has a market cap of $125.73 billion, a PE ratio of 33.97, a price-to-earnings-growth ratio of 2.10 and a beta of 0.76. The business’s 50-day simple moving average is $327.39 and its 200 day simple moving average is $332.16.

Stryker (NYSE:SYK) last posted its quarterly earnings results on Thursday, July 30th. The medical technology company reported $3.69 EPS for the quarter, beating the consensus estimate of $3.49 by $0.20. Stryker had a return on equity of 23.63% and a net margin of 14.43%.The firm had revenue of $6.59 billion during the quarter, compared to analysts’ expectations of $6.58 billion. During the same quarter in the prior year, the firm posted $3.13 EPS. The company’s revenue for the quarter was up 9.4% on a year-over-year basis. Stryker has set its FY 2026 guidance at 14.950-15.100 EPS. On average, research analysts anticipate that Stryker Corporation will post 15.02 earnings per share for the current year.

Stryker Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, October 30th. Shareholders of record on Wednesday, September 30th will be issued a $0.88 dividend. This represents a $3.52 annualized dividend and a yield of 1.1%. The ex-dividend date of this dividend is Wednesday, September 30th. Stryker’s payout ratio is 36.48%.

Stryker Profile

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.